Objective: Our studies in hypertensive Ren-2 transgenic rats (TGR) demonstrated that chronic administration of atrasentan (ETA receptor antagonist) decreased blood pressure by reduced Ca 2+ influx through L-type voltage-dependent calcium channels (L-VDCC) and attenuated angiotensin II-dependent vasoconstriction. We were interested whether bosentan (nonselective ETA/ETB receptor antagonist) would have similar effects.
INTRODUCTION
Ren-2 transgenic rat (TGR) is a typical model of angiotensin II-dependent hypertension in which the insertion of the mouse renin-2 gene into the genome of Hannover Sprague Dawley (HanSD) rats is associated with high blood pressure [Mullins et al, 1990 ].
Our previous study demonstrated that the contribution of distinct vasoactive systems regulating blood pressure is age and strain dependent. Thus, RAS-dependent vasoconstriction is higher in homozygous rats and its role declines with the age of animals in both strains. By There is some controversy on the superiority of the selective ETA over the nonselective (dual) ETA/ETB receptor blockade. Some authors favor the selective ETA blockers due to their antihypertensive, anti-inflammatory and antiproliferative effects, while others prefer the use of dual ETA/ETB endothelin receptor blockers [Vaněčková et al, 2018] .
Our studies in Ren-2 transgenic rats have shown that atrasentan decreased blood pressure and reduced cardiac hypertrophy in both young and adult heterozygous as well as homozygous Endothelin-1 production is enhanced during increased salt intake; this occurs in the renal collecting duct: specifically the inner medullary collecting duct (IMCD), which upon stimulation by high salt intake produces ET-1 to promote the elimination of salt load by autocrine inhibition of Na + reabsorption [Kohan et al, 2011] . Moreover, Herrera et al [2005] reported that with a high salt intake, medullary tonicity increased -this process being associated with the activation of ETB receptors which leads to enhanced eNOS activity, NO production and inhibition of Na + transport in renal thick ascending limb in vitro.
Therefore, we were interested (i) whether bosentan could have some effects on the major vasoactive systems contributing to BP maintenance, and (ii) whether nonselective endothelin receptor blockers might, similar to selective ETA receptor blockade, affect the NOdependent vasodilation and calcium influx through the voltage-dependent calcium channels.
MATERIALS AND METHODS

Ethics statement
All the procedures and experimental protocols were approved by the Ethical
Committee of the Institute of Physiology, Czech Academy of Sciences (Protocol Nr.
139/2013), and conform to the European Convention on Animal Protection and Guidelines on
Research Animal Use (Directive 2010/63/EU).
Animals and in vivo experimental strategies
Four-week-old young (prevention study) or 8-week-old adult (regression study) male heterozygous (mRen-2)27 transgenic rats (TGR) and their transgene-negative control
Hannover Sprague Dawley (HanSD) rats were housed at 23 o C under a 12 h light/dark cycle, given a normal salt diet (0.6 % NaCl) or high-salt diet (2.0 % NaCl) and tap water ad libitum for 8 weeks. The additional group of TGR fed a high-salt diet was treated with bosentan, which was mixed to the diet (100 mg/kg/day).
All rats used in this study were bred at the Institute of Clinical and Experimental
Medicine from stock animals supplied by the Max Delbrück Center for Molecular Medicine in Berlin, Germany.
After 8 weeks of treatment, the involvement of major vasoactive systems (RAS, SNS and NO) contributing to blood pressure regulation was determined. Additionally, the calcium influx through the L-type voltage-dependent calcium channel (L-VDCC) was evaluated after the complete blockade of major vasoactive systems. One day prior to the experiment, the cannulation of the carotid artery (PE 50) and the jugular vein (PE 10) was performed under 2.5 % isoflurane anesthesia to enable BP measurement and the infusion of drugs, respectively.
The cannulae were exteriorized in the interscapular region. Blood pressure and heart rate (HR) were recorded using a pressure transducer and a multichannel recorder (ADInstruments, Bella Vista, Australia) employing the modified protocol of Minami et al (1995) . Briefly, rats were adapted in transparent plastic cages for 30 min. Then, the RAS blockade with captopril (10 mg/kg) started followed by the ganglionic blockade of SNS with pentolinium (5 mg/kg) 15 min later. After NO synthase inhibition with L-NAME (30 mg/kg), the BP was monitored for a further 20 min. Finally, the L-type voltage-dependent calcium channel blocker nifedipine (5 mg/kg) was administered following NO-donor nitroprusside (5 mg/kg). The BP levels before and after particular blockades were determined and the respective BP changes were calculated. All drugs were dissolved in saline and administered as intravenous bolus injections in a volume of 1 ml/kg of body weight. At the end of the experiment the rats were euthanized by anesthetic overdosage and their hearts and kidney were weighed.
Drugs
All drugs were purchased from Sigma (St Louis, Missouri, USA) except for bosentan (a contribution from Martine Clozel, Actellion).
Statistical analysis
The results are expressed as the mean ± SEM. The statistical differences were evaluated by one-way and two-way analysis of variance (ANOVA) (Instat, La Jolla, California, USA) followed by the Fisher LSD post-hoc test. P<0.05 values were considered to be statistically significant.
RESULTS
The blood pressure of TGR animals on a normal salt diet was significantly elevated compared to normotensive HanSD rats in both the prevention and regression studies (Fig. 1 ).
The BP difference was more pronounced in young animals than in adults (181±5 mmHg vs. 156±5mm Hg). The feeding of a high-salt diet had no effect on the BP in either HanSD rats or TGR in both studies. However, it increased the relative kidney weights in TGR rats in both studies and cardiac hypertrophy in TGR in the prevention study (Table 1) . Bosentan did not exert any effect on BP or body parameters in TGR.
The contribution of Ang II-dependent vasoconstriction was proportional to basal BP level -being four-fold higher in young TGR in the prevention study while only two-fold higher in adult TGR in the regression study ( Fig. 2A, D) . By contrast, although the sympathetic vasoconstriction substantially contributed to the increased BP in both age groups of TGR, its contribution was greater in adult TGR (Fig. 2B, E) . No effects of a high-salt diet or bosentan on angiotensin II-dependent or sympathetic vasoconstriction were observed.
NO-dependent vasodilation was not different between TGR and control HanSD
animals in either study (Fig. 2C, F) . In addition, the high-salt diet had no effect on this parameter in hypertensive or normotensive rats. On the other hand, bosentan significantly lowered NO-dependent vasodilation in both the prevention and regression studies. This was also true for nifedipine-sensitive BP reduction elicited by the inhibition of calcium influx through the voltage-dependent calcium channels (Fig. 3) . Moreover, we analyzed the relationship between the MAP measured after NO synthase inhibition with L-NAME and nifedipine-sensitive BP change and we found a highly significant correlation of these parameters in both the prevention and regression studies ( Fig. 4A and 4B ).
DISCUSSION
Our study demonstrated that i) high-salt intake did not aggravate hypertension development in TGR rats, ii) their high BP is dependent on different vasoconstrictor systems in young and adult hypertensive rats, iii) although bosentan had no effect on blood pressure and hence on the major vasoactive systems contributing to BP maintenance, it significantly decreased NOdependent vasodilation and nifedipine-sensitive calcium influx through the voltage-dependent calcium channels.
The blood pressure of hypertensive heterozygous male TGR was significantly higher in young rats than in the adults. This finding is quite intriguing since this phenomenon -decreasing BP with advancing age -was typically described for female TGR (Cargnelli et al, 1998;
Vaneckova et al, KBPR, 2011) but only rarely for aged male TGR (Kasper et al., 2005) . A high-salt intake did not influence the blood pressure level either in the preventive or in the regression study, suggesting that young heterozygous TGR animals are not more sensitive to the increased sodium intake.
We confirmed our previous findings (Vaněčková et al., Hypertens Res, 2012) that the contribution of major vasoconstrictor systems to high blood pressure in heterozygous TGR is age-dependent -RAS-dependent vasoconstriction being the leading system in young animals while the sympathetic-vasoconstriction prevailed with advancing age.
The fact that we did not observe any blood pressure lowering effect of nonselective endothelin receptor antagonist bosentan in Ren-2 transgenic rats is not unexpected since both By contrast, a substantial decrease of L-NAME-induced NO-dependent vasorelaxation was discerned in bosentan treated salt-loaded TGR, which is a finding similar to that seen with a selective endothelin receptor A antagonist atrasentan in our previous study [Vaněčková et al., 2015] . While the reduction of NO-dependent vasodilation is understandable in the present study with bosentan, having in mind that ETB receptors mediate the endothelin effects on nitric oxide and cyclooxygenase production, the same finding with a selective ETA blockade was rather surprising. We cannot offer a satisfactory explanation for this finding but one should consider a possible interaction of both receptors which has been recently described by . Our previous assumption that this is associated with a higher activation of endothelininduced calcium influx due to high-salt intake could be excluded since this was true only in the regression study but not in the prevention study. Our correlation analysis revealed that a nifedipine-induced BP change correlates strongly with the basal BP, a phenomenon which has been reported for other hypertensive strains [Zicha et al., 2014] . However, when the saltloaded TGR subjected to bosentan treatment was added, the correlation was attenuated. In addition, a highly important correlation of nifedipine-induced BP change was also observed for the BP after L-NAME administration, thus suggesting a major role of nitric oxide in the closure of L-type voltage dependent calcium channels.
In conclusion, the selective or nonselective endothelin receptor antagonists share important similarities which are independent of blood pressure, both groups affecting NO-dependent vasodilation and calcium influx through L-type voltage-dependent calcium channels. Fig. 1 . The blood pressure of young (preventive study)(A) and adult (regression study)(B) normotensive control Hannover Sprague Dawley (HanSD) and hypertensive heterozygous Ren-2 trasgenic rats (TGR) on normal salt (NS) diet, high-salt (HS) diet, or HS treated with nonselective ETA/ETB receptor antagonist bosentan (Bos) measured at the end of the study.
FIGURE LEGENDS
The data are the means ± SEM. * p˂0.05, vs. control HanSD rats. 
